A clinical, neuropsychological and olfactory evaluation of a large family with LRRK2 mutations

Parkinsonism and Related Disorders

Volumn 15, Issue 4, 2009, Pages 273-276

  Lohmann, Ebba ^a,b,c   Leclere, Laurence ^a,c   De Anna, Francesca ^b   Lesage, Suzanne ^a,c   Dubois, Bruno ^a,b   Agid, Yves ^a,b,c   Dürr, Alexandra ^a,b,c   Brice, Alexis ^a,b,c  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

G2019S mutation; Leucine rich repeat kinase 2 (LRRK2) gene; Olfaction; Parkinson disease (PD); Presymptomatic marker

Indexed keywords

ANTIDEPRESSANT AGENT; LEUCINE RICH REPEAT KINASE 2; LEVODOPA;

ADULT; AGED; ARTICLE; ATRESIA; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; DISEASE MARKER; DYSKINESIA; EAR ATRESIA; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; MALE; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; OLFACTORY DISCRIMINATION; PARKINSON DISEASE; PRIORITY JOURNAL; TYMPANOPLASTY;

AGED; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; FEMALE; FRANCE; GENETIC PREDISPOSITION TO DISEASE; GLYCINE; HUMANS; MALE; MIDDLE AGED; MUTATION; NEUROPSYCHOLOGICAL TESTS; OLFACTION DISORDERS; PARKINSON DISEASE; PROTEIN-SERINE-THREONINE KINASES; SERINE;

EID: 64549084210     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2008.06.008     Document Type: Article

References (13)

1. Gasser T. Update on the genetics of Parkinson's disease. Movement Disorders 22 Suppl. 17 (2007 Sep) S343-S350
2. Khan N.L., Jain S., Lynch J.M., Pavese N., Abou-Sleiman P., Holton J.L., et al. Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data. Brain 128 Pt 12 (2005 Dec) 2786-2796
3. Saunders-Pullman R., Lipton R.B., Senthil G., Katz M., Costan-Toth C., Derby C., et al. Increased frequency of the LRRK2 G2019S mutation in an elderly Ashkenazi Jewish population is not associated with dementia. Neuroscience Letters 402 1-2 (2006 Jul 10) 92-96
4. Ponsen M.M., Stoffers D., Booij J., van Eck-Smit B.L., Wolters E., and Berendse H.W. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Annals of Neurology 56 2 (2004 Aug) 173-181
5. Haehner A., Hummel T., Hummel C., Sommer U., Junghanns S., and Reichmann H. Olfactory loss may be a first sign of idiopathic Parkinson's disease. Movement Disorders 22 6 (2007 Apr 30) 839-842
6. Lesage S., Ibanez P., Lohmann E., Pollak P., Tison F., Tazir M., et al. G2019S LRRK2 mutation in French and North African families with Parkinson's disease. Annals of Neurology 58 5 (2005 Nov) 784-787
7. Doty R.L., Bromley S.M., and Stern M.B. Olfactory testing as an aid in the diagnosis of Parkinson's disease: development of optimal discrimination criteria. Neurodegeneration 4 1 (1995 Mar) 93-97
8. Daniel S.E., and Hawkes C.H. Preliminary diagnosis of Parkinson's disease by olfactory bulb pathology. Lancet 340 8812 (1992 Jul 18) 186
9. Braak H., and Del Tredici K. Nervous system pathology in sporadic Parkinson disease. Neurology 13 20 (2008 May) 1916-1925
10. Seiden A.M., and Duncan H.J. The diagnosis of a conductive olfactory loss. The Laryngoscope 111 1 (2001 Jan) 9-14
11. Kopala L.C., Good K.P., and Honer W.G. Olfactory hallucinations and olfactory identification ability in patients with schizophrenia and other psychiatric disorders. Schizophrenia Research 12 3 (1994 Jun) 205-211
12. Royall D.R., Chiodo L.K., Polk M.S., and Jaramillo C.J. Severe dysosmia is specifically associated with Alzheimer-like memory deficits in nondemented elderly retirees. Neuroepidemiology 21 2 (2002 Mar-Apr) 68-73
13. Goldwurm S., Zini M., Mariani L., Tesei S., Miceli R., Sironi F., et al. Evaluation of LRRK2 G2019S penetrance: relevance for genetic counseling in Parkinson disease. Neurology 68 14 (2007 Apr 3) 1141-1143